Pharmaceutical composition and application of same in preparation of medicines used for treating cerebrovascular diseases
A cerebrovascular disease and composition technology, applied in the field of medicine, can solve problems such as reducing the application effect, and achieve the effects of reducing the effective dose, increasing the therapeutic effect, and improving the protective effect.
Active Publication Date: 2014-12-17
NANJING SIMCERE DONGYUAN PHARM CO LTD +1
View PDF1 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
A variety of adverse reactions were observed clinically, including: (1) bleeding tendency; (2) occasional elevation of glutamate-grass transaminase (GOT), glutamate-alanine transaminase (GPT) and blood urea nitrogen (BUN) in the liver and kidney; ( 3) The digestive system occasionally has nausea, vomiting, diarrhea, loss of appetite, and fullness; (4) Allergic reactions: occasionally urticaria, rash, etc.; (5) Circulatory system: occasionally supraventricular arrhythmia, blood pressure drop; (6) Others: occasional headache, fever, pain at the injection site, shock and thrombocytopenia, etc.; These adverse reactions reduce its clinical application effect
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0029] Take trans-3-[4-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid sodium 2.50g (grams) [that is, 0.01mol (moles)], add 160g of propylene glycol solution, stir Make it completely dissolved, slowly add water for injection to dissolve it to 1000ml (milliliter), that is to say.
Embodiment 2
[0031] Take (+)-2-camphor 1.54g (ie 0.01mol), add it to 160g of propylene glycol solution, stir to dissolve completely, slowly add water for injection to dissolve to 1000ml, to obtain.
Embodiment 3
[0033] Take 1.54g (ie 0.01mol) of (-)-2-camphor, add it to 160g of propylene glycol solution, stir to dissolve completely, slowly add water for injection to dissolve it to 1000ml, and obtain.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention relates to the field of medicine and discloses a pharmaceutical composition and application of the same in preparation of medicines used for treating cerebrovascular diseases. The pharmaceutical composition comprises trans-3-[4-(1H-imidazole-1-ylmethyl)phenyl]-2-sodium acrylate and 2-borneol.
Description
technical field [0001] The present invention relates to the field of medicine, in particular to a pharmaceutical composition and its application, more specifically to a pharmaceutical composition and its application in the preparation of medicines for treating cerebrovascular diseases. Background technique [0002] Cerebrovascular disease is a group of diseases that seriously endanger human health, and has become one of the important causes of human disability and death. Cerebrovascular disease (CVD for short) refers to brain lesions caused by abnormalities in cerebrovascular vessels. Stroke generally refers to acute cerebrovascular disease. [0003] Cerebrovascular diseases can be simply divided into two categories, one is ischemic cerebrovascular disease caused by the reduction or interruption of blood flow, and the other is hemorrhagic cerebrovascular disease caused by rupture of blood vessels. Ischemic cerebrovascular disease is mainly cerebral infarction (including ce...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4174A61K31/045A61P9/10
Inventor 张正平杨士豹廖高勇
Owner NANJING SIMCERE DONGYUAN PHARM CO LTD
PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.
